Major Players - Brachytherapy Industry

The market for brachytherapy is expanding primarily due to an increase in the incidence of prostate cancer. The American Cancer Society estimates that as of 2017, there were around 26.730 prostate cancer-related deaths in the United States and approximately 161,370 new cases of prostate cancer. The third-leading cause of death for males in the United States is prostate cancer. The market for brachytherapy is also expanding as a result of rising high dose rate brachytherapy adoption rates and rising obesity rates. The global brachytherapy market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa on the basis of region. Due to the increasing popularity of the breast microseed treatment for breast cancer, North America is predicted to keep a prominent position in the market. Breast microseed therapy uses brachytherapy to precisely put radioactive seeds in the breast that gradually release the required dose over time in a safe manner.

According to Coherent Market Insights, The market for Brachytherapy, which was valued at $0.83 billion in 2021, is anticipated to increase at a CAGR of 7.1% from 2022 to 2031 to reach $1.6 billion.

Market Players in the Brachytherapy Industry:

1. Elekta

The company was founded in 1972 and has its main office in Stockholm, Sweden. The business creates and manufactures clinical management, radiation therapy, and radiosurgery-related equipment for the treatment of cancer and brain illnesses. Elekta launched Elekta Esprit in May 2022, advancing radiosurgery to a previously unheard-of degree

2. Varian Medical Systems, Inc.

The company was established in 1948 and is located in California, United States. In addition to providing radiation, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing tools, the company also designs, manufactures, sells, and supports medical equipment. Siemens Healthineers made intentions to buy Varian for $16.4 billion public in August 2020.The transaction was finished on April 15, 2021.

3. Theragenics Corporation

The firm was started in 1981 and is based in Georgia, United States. In the production of radioactive brachytherapy seeds for the treatment of localised malignancies, especially prostate cancer, Theragenics is a well-known industry pioneer. The business is a top producer of surgical solutions, specialising in items for speciality surgical applications and wound closure.

4. Sun Nuclear Corporation

The business was started in 1984 and is based in Florida, United States. Throughout the cancer diagnostic and treatment process, Sun Nuclear is the go-to source for independent, comprehensive solutions for quality management. The company announced in October 2022 that it is working with Accuray to provide new Quality Management solutions for its Radixact® System with Synchrony®.

5. Argon Medical Devices

The firm was founded in 1972 and is located in Frisco, Texas. Argon Medical Devices creates and develops medical equipment for clinics and healthcare providers all over the world. In November 2021, the company released two unique portal vein access sets for transjugular liver access during diagnostic and interventional operations. Argon Medical Devices, Inc. declared in January 2020 that Single-Loop and Triple-Loop Retrieval Kits would go on sale in the United States.

6. Eckert & Ziegler BEBIG

The company was established in 1997 and is based in Berlin, Germany. The business produces and sells radioactive implants and drugs for the treatment of cancer. With the help of the company's implants, the cancer is killed locally without causing any harm to the tissues around it. Ziegler & Eckert The international marketing of BEBIG's product line is supported by a global network of distributors and agents. 

7. IsoRay Medical

The business was founded in 2004 and has its main office in Washington, United States. Isoray creates cutting-edge, individualised brachytherapy products that successfully treat a variety of cancer types. Innovative business IsoRay creates and develops goods for more affordable cancer therapy.

*Definition:

When treating different types of cancer, brachytherapy, a type of radiotherapy, is often employed. Internal radiation or seed therapy are additional names for it. In brachytherapy, a sealed radiation source is positioned inside or close to the area that has to be treated.